Alkermes (ALKS) Tops Q2 EPS by 7c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $45.89 +0.44%
Financial Fact:
Selling, general and administrative: 11.1M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Selling, general and administrative: 11.1M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.06, $0.07 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $247.5 million versus the consensus estimate of $232.75 million.
GUIDANCE:
Alkermes sees FY2020 EPS of $0.00-$0.19, versus the consensus of ($0.01). Alkermes sees FY2020 revenue of $965-1005 million, versus the consensus of $983 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alkermes (ALKS) PT Raised to $50 at H.C. Wainwright
- National Fuel Gas (NFG) Tops Q4 EPS by 18c; offers guidance
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
